Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,670 shares at $116.78 ($195K) on 2017-06-15, disclosed to the SEC on 2017-06-16.
Open-market sale of $195k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.78 | 835 | $98K | 50.0% |
| 2 | $116.78 | 835 | $98K | 50.0% |
| Total | $116.78 avg | 1,670 | $195K | 100% |
| Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |
| ALXN | SELL | 2014-05-15 | $2.0M | — | Filing → |